Clinical Trial Update: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler

View source ↗

Summary

This entry reports a terminated clinical trial (NCT01463410) evaluating the accuracy of chromosomal aberration and gene mutation markers for the AMLProfiler in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Promyelocytic Leukemia
• Anemia with Excess Blasts

Snippet

Sponsor: Skyline Diagnostics BV | Conditions: Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia (APL) | Status: TERMINATED